StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Seattle Genetics (SGEN) PT Raised to $200 at JMP Securities After Positive ESMO Data and Commentary
September 22, 2020 6:31 AM
JMP Securities analyst Reni Benjamin raised the price target on Seattle Genetics (NASDAQ: SGEN) to $200.00 (from $185.00) after the ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst PT Change